CN100475247C - External application medicine for treating vertebrae lumbales hyperosteogeny - Google Patents
External application medicine for treating vertebrae lumbales hyperosteogeny Download PDFInfo
- Publication number
- CN100475247C CN100475247C CNB2006101512271A CN200610151227A CN100475247C CN 100475247 C CN100475247 C CN 100475247C CN B2006101512271 A CNB2006101512271 A CN B2006101512271A CN 200610151227 A CN200610151227 A CN 200610151227A CN 100475247 C CN100475247 C CN 100475247C
- Authority
- CN
- China
- Prior art keywords
- gram
- hyperosteogeny
- treatment
- external application
- agkistrodon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
An externally-applied Chinese medicine in the form of ointment for treating lumbar and cervical hyperosteogeny is prepared from 8 Chinese-medicinal materials including Dragon's blood, centipede, scorpion, musk, etc.
Description
(1) technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of pharmaceutical product for the treatment of the neck lumbar vertebra hyperosteogeny.
(2) background technology
The neck lumbar vertebra hyperosteogeny is that a kind of common, sickness rate is than higher frequently-occurring disease.The medicine for the treatment of this disease has a lot, and Chinese patent medicine pill, medicated wine, Chinese medicine decoction or the like are arranged, but all has undesirable, the easy recurrence of effect, control problems such as difficulty heals for a long time.Strengthen medical skill, improve treatment level, be still waiting further research.
(3) summary of the invention
The object of the present invention is to provide a kind of topical agent of eutherapeutic treatment neck lumbar vertebra hyperosteogeny.
The object of the present invention is achieved like this: it by weight ratio is: Agkistrodon 20-30 gram, Zaocys 5-15 gram, Sanguis Draxonis 5-10 gram, Bombyx Batryticatus 20-30 gram, Scolopendra 2-4 bar, Scorpio 5-15 gram, Radix Angelicae Dahuricae 20-35 gram restrain with Moschus 0.5-1.
Need be when the present invention prepares with the Scorpio parch, Agkistrodon, Zaocys are put into wine to be concocted 2-3 hour, together dry with other drug again, grind then and be fine powder, with vaseline oil furnishing pasty state, wherein, play adhesive effect to get final product after sieving for guaranteeing that the drug effect vaseline oil can not be too much, after mixing well ointment is made patch, pack gets final product.
During use ointment is applied in the affected part, take off after 5 days summers, take off 7 days winters, waits to paste the medicine position after rest 1-3 days and can continue to apply next after normal and paste medicine.Adjust the application time according to the weight of disease, light disease gets final product a course of treatment, and two courses of treatment of medium disease, serious symptom gets final product three courses of treatment, drug of topical application course of treatment five times.
Agkistrodon is used for the treatment of scrofula, carbuncle malignant boil in the composition of the present invention, and the effect of the counteracting toxic substances of dispeling the wind is arranged, and treats diseases such as obstinate arthralgia pain, hemiplegia, and the Agkistrodon extract also has analgesia, sedation, and tendons relaxing and meridians dredging; Zaocys is controlled pyretic toxicity wind, skin and is given birth to skin ulcer, the same Agkistrodon of function, and Zaocys is nontoxic and power is shallow, can heighten the effect of a treatment with the Agkistrodon compatibility, and being used for the treatment of bone tuberculosis clinically has certain curative effect; The dragon blood for treating traumatic injury, have eliminate the phlegm, the effect of circulation of qi promoting, promoting blood circulation and stopping pain, " traumatic fracture beat decrease, blood trouble is gathered in all pains " gone up and is said to " Haiyao Bencao, Oversea Materia Medica ", Compendium of Material Medica then claims " controlling all pains of dissipating blood stasis blood "; Bombyx Batryticatus is wind-expelling pain-stopping, blood stasis-eliminating and stagnation-dissipating then, can be used for scrofula, expectorant is coughed; Scolopendra has the curative effect of endogenous wind stopping pain relieving, detoxicating and resolving stagnation of pathogens, can treat all pyogenic infections from tumour or sore, and stronger inducing menstruation to relieve menalgia, Detoxication are arranged; Scorpio has the curative effect of detoxifcation, eliminating stagnation, inducing menstruation to relieve menalgia, can be used for diseases such as all pyogenic infections from tumour or sore, scrofula tuberculosis; The effect of the Radix Angelicae Dahuricae dispel the wind detoxifcation, reducing swelling and alleviating pain; Moschus is blood circulation promoting and dispersing pathogen accumulation, reducing swelling and alleviating pain then, is used for the treatment of amenorrhea, traumatic injury, and normal and blood circulation and stasis-eliminating medicine is associated with.
The present invention becomes external application medical ointment with above eight flavor Chinese medicine processing, can be used for treating neck lumbar vertebra hyperosteogeny disease, doublely again controls diseases such as prolapse of lumbar intervertebral disc, spondylitis, spinal canal stenosis, lumbar sprain.Through clinical verification, drug effect of the present invention is rapid, has no side effect, and curative effect is more more remarkable than decoction, acupuncture, massage curative effect, and treatment lumbar vertebra hyperosteogeny and none routine nonresponder of hyperosteogeny of cervical vertebra add up 100 routine effective percentage up to 100%, and cure rate is more than 94%.In the clinical trial, hyperosteogeny case 40 examples are cured 21 examples one course of treatment, and ratio is to cure 9 examples 52.5%, two course of treatment, ratio is to cure 4 examples 22.5%, three course of treatment, and ratio is above 6 examples of curing 10%, three course of treatment, ratio is 15%, 2 example recurrences after half a year, total effective rate 100%, cure rate 95%; Prolapse of lumbar intervertebral disc 10 examples, hyperosteogeny 50 examples are cured 29 people one course of treatment, and ratio is to cure 22 examples 48.33%, two course of treatment, cures 9 people 36.67%, three course of treatment, and ratio is 15%, 4 example recurrences after half a year, total effective rate 100%, total cure rate 94%.
(4) specific embodiment
The present invention is further illustrated below in conjunction with specific embodiment:
Embodiment 1:
Present embodiment comprises Agkistrodon 20 grams, Zaocys 5 grams, Sanguis Draxonis 5 grams, Bombyx Batryticatus 20 grams, 2 of Scolopendras, Scorpio 10 grams, the Radix Angelicae Dahuricae 25 grams and Moschus 0.5 gram.
Elder generation is with the Scorpio parch during preparation, Agkistrodon, Zaocys are put into wine to be concocted 2 hours, together dry with other drug again, grinding then is fine powder, with vaseline oil furnishing pasty state, wherein is to guarantee that the drug effect vaseline oil can not be too much after sieving, playing adhesive effect gets final product, after mixing well ointment is made patch, the ointment THICKNESS CONTROL is between 0.2-0.3mm, and pack gets final product.
Embodiment 2:
Present embodiment comprises Agkistrodon 30 grams, Zaocys 10 grams, Sanguis Draxonis 5 grams, Bombyx Batryticatus 30 grams, 3 of Scolopendras, Scorpio 15 grams, the Radix Angelicae Dahuricae 25 grams and Moschus 1 gram.
Elder generation is with the Scorpio parch during preparation, Agkistrodon, Zaocys are put into wine to be concocted 3 hours, together dry with other drug again, grinding then is fine powder, with vaseline oil furnishing pasty state, wherein is to guarantee that the drug effect vaseline oil can not be too much after sieving, playing adhesive effect gets final product, after mixing well ointment is made patch, the ointment THICKNESS CONTROL is between 0.2-0.3mm, and pack gets final product.
Claims (1)
1, a kind of topical agent for the treatment of the neck lumbar vertebra hyperosteogeny is characterized in that it by weight ratio is: Agkistrodon 20-30 gram, Zaocys 5-15 gram, Sanguis Draxonis 5-10 gram, Bombyx Batryticatus 20-30 gram, Scolopendra 2-4 bar, Scorpio 5-15 gram, Radix Angelicae Dahuricae 20-35 gram restrain with Moschus 0.5-1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101512271A CN100475247C (en) | 2006-12-30 | 2006-12-30 | External application medicine for treating vertebrae lumbales hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101512271A CN100475247C (en) | 2006-12-30 | 2006-12-30 | External application medicine for treating vertebrae lumbales hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101002867A CN101002867A (en) | 2007-07-25 |
| CN100475247C true CN100475247C (en) | 2009-04-08 |
Family
ID=38702393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101512271A Expired - Fee Related CN100475247C (en) | 2006-12-30 | 2006-12-30 | External application medicine for treating vertebrae lumbales hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100475247C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102688269A (en) * | 2012-06-25 | 2012-09-26 | 李金果 | External powder patch for treating hyperosteogeny |
| CN103768175B (en) * | 2014-01-16 | 2015-06-10 | 河南省超亚医药器械有限公司 | Medicine for treating protrusion of lumbar intervertebral disc and drug-separated moxibustion of medicine |
-
2006
- 2006-12-30 CN CNB2006101512271A patent/CN100475247C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 骨质增生的治疗近况. 孙玉凤.河北中医药学报，第13卷第4期. 1998 |
| 骨质增生的治疗近况. 孙玉凤.河北中医药学报，第13卷第4期. 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101002867A (en) | 2007-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1255172C (en) | Medical paste for rheumatism and bone ache | |
| CN101347559A (en) | Medicament for treating ulcer of skin | |
| CN101244226A (en) | Chinese medicine composition for treating traumatic injury | |
| CN101850092A (en) | Medicament for treating trauma and preparation method thereof | |
| CN100394954C (en) | External compressing red ointment | |
| CN100475247C (en) | External application medicine for treating vertebrae lumbales hyperosteogeny | |
| CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
| CN100396316C (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN103223077B (en) | Traditional Chinese medicine composition for treating burn and scald | |
| CN101507784B (en) | Traditional Chinese medicine capable of promoting fracture healing | |
| CN110179960A (en) | A kind of composition and its acupoint plaster for treating shoulder pain after apoplexy | |
| CN101700399B (en) | Traditional Chinese medicine ointment for treating lumbar muscle fasciitis | |
| CN102846884A (en) | Analgesia plaster and preparation method thereof | |
| CN101417059B (en) | Ointment for treating burn and scald and preparation method thereof | |
| CN101721580A (en) | Bone-knitting Chinese medicament | |
| CN101411774B (en) | External-use medicament for treating appendicitis | |
| CN1189192C (en) | Chinese medicinal preparation for treating fracture | |
| CN1191085C (en) | Quick-acting ointment for treating burns, scalds and knife wound | |
| CN100364603C (en) | Externally used Chinese herbal medicinal composition | |
| CN1113777A (en) | Xugu powder for promoting reunion of fractured bones and its producing method | |
| CN1958064A (en) | Chinese traditional medicine for external application of treating rheumatism like disease, preparation method and usage | |
| CN103585257A (en) | Traditional Chinese medicine powder for treating fractures | |
| CN1058409C (en) | Medicine for quickly curing osteoproliferation | |
| CN101194979B (en) | Powder medicament for treating herpes stomatitis | |
| CN100531780C (en) | Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090408 Termination date: 20131230 |